Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Princeton’s Intellectual Property Accelerator Fund Supports Research that Can Make a Difference

4/22/2016

0 Comments

 
​Princeton, NJ ― Five projects — ranging from a way to make the Internet of Things more secure to a new strategy for discovering antibiotics — have been awarded funding through Princeton's Intellectual Property Accelerator (IPA) Fund.  
 
The projects were chosen for their potential to become technologies or products that can benefit society.
 
Awarded annually by the Office of Technology Licensing, the fund supports research activities that help demonstrate the potential for a technology to transition from a university research project to a product or service that can improve people's lives.
 
The funding of up to $100,000 per project will go to support proof-of-concept work, data collection, the construction of prototypes and other activities aimed at exploring the capability of the technologies. 
​Secure networking for medical devices
 
As more devices become connected via the Internet of Things, security and privacy have become significant issues. Professor of Electrical Engineering Niraj Jha has received funds for the development of two technologies that protect the security of implantable and wearable medical devices such as pacemakers, cochlear implants and drug delivery systems.
 
Such devices are increasingly connected via wireless communications to smartphones, smart watches or other personal devices. These wireless communications are vulnerable to attacks that could disclose sensitive data or hijack the devices' functionality with life-threatening results.
 
To combat such attacks, Jha and his team have invented two security technologies, MedMon and SecureVibe. MedMon detects potentially malicious transactions and takes action to prevent illegitimate and life-threatening commands from being accepted by the device. SecureVibe enables secure connections and communication using key-exchange cryptography between the implanted device and the external smartphone.
 
With IPA funding, the team will miniaturize the MedMon and SecureVibe technologies so that they can be incorporated into devices that can be worn on a belt or placed in a pocket where they can protect a patient's medical devices from cyberthreats.
 
Improved wireless communication with photonics
 
With so many smartphones and other cellular devices using today's wireless spectrum, call and data quality can be disrupted when signals interfere. To reduce this interference, nearly all wireless devices, including smartphones, contain a large number of filters, switches and other components that take up a large amount of space on the device's circuit board that could instead add to the device's functionality and performance.
 
A team Professor of Electrical Engineering Paul Prucnal leads is developing technology capable of canceling interference that is cheaper, simpler and takes up less space inside the phone. The technology involves a new type of computer chip that uses light rather than electrons to process signals.
 
The new processor, called a photonic integrated circuit (PIC), can perform nearly all the necessary communications functions at a fraction of the size of today's filters and switches.  The processor can be made at low cost using existing semiconductor manufacturing capabilities.
 
It consolidates a large number of filters, switches and duplexers into just a few PICs, which can operate over a wide bandwidth, an important capability as file sizes and transfer speeds continue to grow. With IPA funding, the team will improve the PIC performance to the point where it is ready for further development.
 
Cheap and portable diagnostics
 
The ability to quickly diagnose diseases could enable health care workers to respond rapidly to emerging pathogens, improve patient outcomes, and perhaps even change the course of an outbreak.
 
Assistant Professor of Electrical Engineering Kaushik Sengupta and his team are developing a technology to detect proteins and genetic material linked to human diseases in a portable and low-cost biosensor that practitioners can use in the field.
 
To build the new portable diagnostic device, the team has found a way to miniaturize a fluorescence-based system that requires bulky and expensive components available only in laboratory settings. Sengupta and his team have developed a silicon-based technology that combines complex optical and electronic components into a single chip that can be manufactured using existing semiconductor fabrication processes at low cost.
 
Using traditional integrated circuit technology, the team has created optical filters as well as with the necessary electronics to process fluorescent signals, allowing the simultaneous detection of thousands of different molecules. Eventually, the team hopes that these biosensors could be deployed in the field where the test results could be sent via wireless technology to a clinic or hospital. 
 
New tactic for discovering new antibiotics
 
Bacteria that resist treatment with antibiotics are a growing problem worldwide, and new families of antibiotics are sorely needed. Most clinical antibiotics in use today are derived from compounds that bacteria produce to kill other bacteria.  Yet genomic research hints that there are many more of these antibacterial compounds waiting to be discovered, encoded in rarely expressed "silent" or "cryptic" gene clusters.
 
To mine these silent gene clusters for new compounds, Assistant Professor of Chemistry Mohammad Seyedsayamdost and his team have invented a systematic method for detecting molecular signals that turn on gene expression in the clusters.
 
The method involves screening small molecule libraries to find ones that activate expression of the clusters, and then evaluating the resulting secreted product for antibiotic activity. The researchers have already demonstrated that the technique is capable of finding antibiotic compounds. With IPA funds, the team will improve the screening process and ramp up the ability of the technique to detect novel antibiotics with human therapeutic potential.
 
Antivirals against hepatitis B
 
Hepatitis B affects more than 2 billion people worldwide, yet few patients receive adequate treatment and even fewer are cured. Discoveries about the life cycle of this virus, which establishes a chronic infection of the liver, have provided insight on a new way to attack the virus.
 
Assistant Professor of Molecular Biology Alexander Ploss and his team are working on a strategy to block the virus by targeting enzymes in the human liver that help the virus replicate.
 
With support from the IPA fund, the team will conduct experiments to explore factors that enable the virus to maintain chronic infection.  The researchers will also screen libraries of small molecules to find candidates that can block factors essential for viral replication with the goal of significantly decreasing hepatitis B or eliminating it altogether.
 
Molecules that show activity in the screen will be further tested in human liver cell culture systems and in mice containing human liver cells, with the goal of discovering promising candidates for therapeutic development.
 

0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Health Care
    Healthcare
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608
732-729-9619